Cargando…
First Insight on Small Molecules as Cardiac Calsequestrin Stabilizers
[Image: see text] Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by mutations of cardiac calsequestrin (CASQ2) that impair its characteristic ability of Ca(2+)-induced polymerization–depolymerization. However, stabilizing the CASQ2 polymer by pharmacological agents to treat C...
Autores principales: | Chakravarty, Harapriya, Bal, Chandralata, Yadav, Monika, Jena, Nivedita, Bal, Naresh C., Sharon, Ashoke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682146/ https://www.ncbi.nlm.nih.gov/pubmed/31460256 http://dx.doi.org/10.1021/acsomega.9b01113 |
Ejemplares similares
-
Characterization of Post-Translational Modifications to Calsequestrins of Cardiac and Skeletal Muscle
por: Lewis, Kevin M., et al.
Publicado: (2016) -
Calsequestrin interacts directly with the cardiac ryanodine receptor luminal domain
por: Handhle, Ahmed, et al.
Publicado: (2016) -
Luminal Ca(2+) Regulation of Single Cardiac Ryanodine Receptors: Insights Provided by Calsequestrin and its Mutants
por: Qin, Jia, et al.
Publicado: (2008) -
Calsequestrin 1 Is an Active Partner of Stromal Interaction Molecule 2 in Skeletal Muscle
por: Jeong, Seung Yeon, et al.
Publicado: (2021) -
Mechanism of calsequestrin regulation of single cardiac ryanodine receptor in normal and pathological conditions
por: Chen, Haiyan, et al.
Publicado: (2013)